Pembrolizumab in Biliary Tract Cancer

NCT03260712 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Biliary Tract Cancer
Metastatic Cancer
Advanced Cancer
Gallbladder Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC